Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial.

ABSTRACT:

SUBMITTER: Edelmann J 

PROVIDER: S-EPMC5332302 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature